Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Medical Responsible
EMD Serono Research & Development Institute, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Cancer Centre
Toronto, Canada
Anna SpreaficoRecruiting - Bc Cancer - Vancouver - Bc Cancer Agency
Vancouver, Canada
Anna TinkerNot, yet, recruiting
- National Cancer Center Hospital
Tokyo, Japan
Noboru YamamotoRecruiting
- Hospital Universitari Vall D'Hebron - Vhio - Oncology - Phase I Unit
Barcelona, Spain
Elena Garralda CabanasNot, yet, recruiting - Next Madrid - Hospital Universitario Quironsalud Madrid
Madrid, Spain
Valentina BoniNot, yet, recruiting
- Yale University - Yale University School of Medicine
New Haven, Connecticut, United States
Patricia M LoRussoNot, yet, recruiting - Carolina Biooncology Institute, Llc - Cancer Therapy and Research Center
Huntersville, North Carolina, United States
John D PowderlyRecruiting - Next Houston
Galveston, Texas, United States
Jennifer M SegarRecruiting - Next Oncology - Parent
San Antonio, Texas, United States
Ildefonso Ismael Rodriguez RiveraRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Feb 2026
- Primary completion
- 20 Sept 2028
- Completion
- 28 Mar 2029
- Last update posted
- 11 Jun 2026
- Registered enrollment
- 138
- Registry id
- NCT07360314
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.